Integra Lifesciences HLD (iart 0.5 08/15/25)
13F holders, Q4 2024 (December 31)2holders −1
0new positions
2sold out
$0.95avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Integra Lifesciences HLD (iart 0.5 08/15/25) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 2 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.9M) and Ofi Invest Asset Management ($2.3M).
- Company
- Integra Lifesciences HLD (iart 0.5 08/15/25)
- CUSIP
- 457985AM1
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $434K |
All 13F filers, Q3 2024 → Q4 2024: 5,451 shares sold, net −5,451 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 3,000,000 | $2.9M |
| Ofi Invest Asset Management | 0.06% | — | 2,500,000 | $2.3M |
"% of holder's portfolio" is INTEGRA LIFESCIENCES HLD (IART 0.5 08/15/25)'s weight in each manager's 13F, not the share of Integra Lifesciences HLD (iart 0.5 08/15/25) the manager owns.